Impact of COVID-19-related public health measures on HCV testing in British Columbia, Canada: An interrupted time series analysis.
Mawuena BinkaSofia R BartlettHéctor Alexander Velásquez GarcíaMaryam DarvishianDahn JeongPrince AduMaria AlvarezStanley WongAmanda YuHasina SamjiMel KrajdenJason WongNaveed Z JanjuaPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
Reductions in HCV testing and first-time HCV-positive diagnosis rates, key drivers of progression along the HCV care cascade, occurred following the introduction of COVID-19-related public health measures. Further assessment will be required to better understand the full impact of these service disruptions on the HCV care cascade and to inform strategies for the re-engagement of people who may have been lost to care because of these measures.